Carprazidil

This classification denotes a vasodilating agent with the molecular formula C12H13N5O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O55EMK06L9, chemically known as methyl 5-(3,6-dihydro-1(2h)-pyridyl)-2-oxo-2h-(1,2,4)oxadiazolo(2,3-a)pyrimidine-7-carbamate but generally known as carprazidil, which bears US NIH Compound Identifier 68875. European Medicines Agency schedules Carprazidil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06143MIG. The term CARPRAZIDIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). CARPRAZIDIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule carprazidil under HS 29349990 and SITC 51579. As of Q4 2014, CARPRAZIDIL remains the US FDA Preferred Term for this commodity. Carprazidil bears US NLM identifiers UMLS ID C0108537 and NCI Concept Code C77148. SMILES: COC(=O)NC1=CC(=NC2=NC(=O)ON12)N3CCC=CC3.